Skip to main content

Table 1 High-priority candidate polymorphisms that may affect motor control.

From: Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Gene*

Molecule

SNP

Location

AA change

Ref

Frequency

 

Function

Relation to Motor Control

Total

      

%

No

   

DRD2/ANKK1

Ankyrin repeat and kinase domain 1

C32806T

3' region/Exon 8

Glu713 Lys

[42]

46

3

3

3

9

GCH1

GTP cyclohydrolase 1

C94A

Exon 1

Thr 94 Lys

[14]

15

2

3

3

8

GLRA1

Glycine receptor 1α

G1192A

Exon 6

Arg271 Glu

[43]

12

2

3

3

8

CACNA1S

Calcium channel, voltage-dependent, L type, α-1S subunit

T2403C

Exon 18

no

[44]

25

3

2

3

8

GABR1A

GABA A receptor 1 α

T156C

Exon 4

Lys278 Met

[45]

28

2

3

3

8

RyR1

Ryanodine receptor 1 gene

G6178T

Exon 38

Gly2060 Val

[46]

12

2

3

3

8

ADRA2C

Adrenergic receptor 2C

12 NT Ins/Del

Coding region/3rd intracellular loop

no

[47]

35

3

2

2

7

5HT2A

Serotonin 2A receptor

T102C

Exon 3

His 452 Tyr

[48]

9

1

3

3

7

GABBR1

GABAB receptor gene 1

G1465A

Exon 11

Gly489 Ser

[49]

10

2

2

2

6

ADRA2A

α2A adrenergic receptor

C1291G

Promoter region

no

[50]

26

2

2

2

6

5HT1A

Serotonin 1A receptor

C1019G

Promoter region

no

[51]

29

2

2

2

6

CNR1

Cannabinoid receptor gene 1

G1359A

Exon1

no

[52]

31

3

0

2

5

CHRM1

Human M1 muscarinic receptor

C1221T

Exon 6

C407

[53]

16

2

1

2

5

Rab3A

Rat brain associated protein 3A

C428T

Exon3

Val72 Met

[54]

26

2

1

2

5

SCN4a

Sodium channel receptor gene

A669G

Exon 12

Arg672 Cys

[55]

NA

0

2

3

5

  1. *Genes listed in bold type were genotyped in this study, along with 5 intermediate-priority polymorphisms